Blog

SNOMED International releases its Q1 news to you, our valued community.  This quarter focuses on our SNOMED CT releases, including the January 2020 International Edition release and interim March 2020 release both representative of COVID-19 content

We celebrate a new Member in our community, and new licensing and education delivery agreements with partners.  Lastly, January 2020 saw the launch of the organization's 2020-2025 Strategy to guide our activities over the next 5 years. 

Read up on developments taking place in 2020, as well as past editions of our newsletter here.

Share your feedback or ideas at comms@snomed.org 






Germany's Medical Informatics Initiative (MII) formally announced a relationship with SNOMED International Wednesday March 18, 2020.  As of last week, the Federal Ministry of Research has given MII participants nationwide a license to use SNOMED CT.

As part of the Medical Informatics Initiative funded by the Federal Ministry of Education and Research (BMBF), the terminology standard can now be used nationwide. This “pilot license” will be initially limited to MII participants and project partners.

Read the full release.  Please send your questions to info@snomed.org. 


On March 11, 2020, the World Health Organization formally characterized COVID-19 as a global pandemic and health systems globally are continuing their efforts to manage the outbreak.
 
SNOMED International recently announced an interim release of the SNOMED CT International Edition outside of its customary release cycle to include updated COVID-19 content as a means of lending its support to the ongoing global effort. 
 
Without reservation, SNOMED International will also include this COVID-19 content, in its recently released Global Patient Set (GPS), a managed list of existing SNOMED CT unique identifiers, fully specified names (FSN), preferred terms in international English, and status flags, made available at no cost to users.  Please note, this content will appear as part of the GPS in the next release in September 2020, but is now available here and can be used under the same open license, the Creative Commons Attribution 4.0 International License.
 
Learn more about the GPS and access provided resources on SNOMED International’s Global Patient Set information page.

For more information, contact info@snomed.org.

SNOMED International maintains and quality assures SNOMED CT on an ongoing basis, issuing releases of its International Edition at the end of January and July each year.
 
In cases where a global emergency persists and warrants action, for example SARS in 2013 and the current COVID-19 situation, SNOMED International has taken steps to issue an interim release of the SNOMED CT International Edition to serve a public good.  With this release, clinicians, researchers and administrators globally are able to code, analyze and plan to address the Coronavirus effort with the most up to date terminology.  
 
The March 2020 interim release contains relevant COVID-19 concepts including any applicable changes to descriptions.  With this interim release, 24 records have been added, plus core concept descriptions added back in referencing March 2020.
 

ConceptID  DescriptionID  Term
8405340013950925017COVID-19 vaccination 
8405440043950926016Suspected COVID-19 
8405350003947177019Antibody to severe acute respiratory syndrome coronavirus 2 (substance) 
8405350003947178012Antibody to severe acute respiratory syndrome coronavirus 2 
8405350003947179016Antibody to SARS-CoV-2 
8405360043947180018Antigen of severe acute respiratory syndrome coronavirus 2 (substance) 
8405360043947181019Antigen of severe acute respiratory syndrome coronavirus 2 
8405360043947182014Antigen of SARS-CoV-2 
8405390063947183016Disease caused by severe acute respiratory syndrome coronavirus 2 (disorder) 
8405390063947184010Disease caused by severe acute respiratory syndrome coronavirus 2 
8405390063947185011COVID-19 
8405460023947186012Exposure to severe acute respiratory syndrome coronavirus 2 (event) 
8405460023947187015Exposure to SARS-CoV-2 
8405460023947188013Exposure to severe acute respiratory syndrome coronavirus 2 
8405330073947189017Severe acute respiratory syndrome coronavirus 2 (organism) 
8405330073947190014SARS-CoV-2 
8405330073947191013Severe acute respiratory syndrome coronavirus 2 
8405340013947192018Severe acute respiratory syndrome coronavirus 2 vaccination (procedure) 
8405340013947193011SARS-CoV-2 vaccination 
8405340013947194017Severe acute respiratory syndrome coronavirus 2 vaccination 
8405440043947195016Suspected disease caused by SARS-CoV-2 
8405440043947196015Suspected disease caused by severe acute respiratory coronavirus 2 
8405440043947197012Suspected disease caused by severe acute respiratory coronavirus 2 (situation) 
1388750053947198019SNOMED Clinical Terms version: 20200309 [R] (March 2020 Interim Release) 


SNOMED CT users have the choice to take this interim release package and import into their systems now, or follow their planned update in July 2020, which will also include all relevant content.
 
To learn more about this release, visit the linked confluence page to review the March 2020 SNOMED CT International Edition Release.


Please contact info@snomed.org with questions or clarifications. 

SENT ON BEHALF OF DON SWEETE


I extend my thanks to you for your patience as we have continued to monitor the developing situation with COVID-19 (coronavirus).  Made apparent by recent reports from the World Health Organization and the Centers for Disease Control and Prevention, there is no doubt that the virus continues to spread globally. 

Myself, in collaboration with the General Assembly Executive, have been constantly involved in discussion over the past few weeks regarding the present situation.  We have now made the difficult decision to cancel the face to face 2020 April Business Meetings to protect the health of our Community and do our part to prevent the spread of this outbreak.

In place of the Community Updates session, we will provide you with a document outlining the headlines from the organization since October 2019 that you can review and then pose your follow up questions with organization representatives.

While we are not rescheduling these meetings, we will support all meetings to go ahead virtually where possible and be in touch with relevant participants.  At this point, we plan to next convene face to face in Portugal, October 2020. 

I thank you for your ongoing support and encourage you to reach out to us with any questions or inquiries you have as a result of this decision. 


Sincerely, 

Don Sweete

CEO, SNOMED International

With the SNOMED International 2020 April Business Meetings in London fast approaching, we wish to provide you with an update about actions that the organization is taking around the global COVID-19 pandemic.  Rest assured that the health, safety and well-being of our community remains our highest priority.


SNOMED International continues to closely monitor the COVID-19 situation and the health risk for the general British public is considered low at this time, according to the latest summary from the UK government's Department of Health and Social Care. 


As of March 4, 2020, SNOMED International’s April Business Meetings are proceeding as scheduled.


We each have a personal responsibility to do our part to incorporate basic, protective measures into our everyday routine.  World Health Organization (WHO) recommended measures include:

  • Frequent hand washing: We have made provisions to have hand sanitizer onsite and readily available.

  • Maintain social distancing: Maintain a 1m distance between yourself and anyone who is coughing or sneezing.

  • Avoid touching eyes, nose and mouth: 2020 April Business Meetings will be a handshake free zone.

  • Practice respiratory hygiene: If you are healthy, you only need to wear a mask (available on site) if you are taking care of a person with suspected COVID-19 infection.


SNOMED International will continue to follow the guidance of the UK government and the WHO and will provide frequent updates to you, our Community of Practice.  We will ensure that easy access to clinicians, personal protective equipment (e.g. masks) and alternatives to in-person participation are available.  We are also communicating regularly with our venue, the Waldorf Hilton London, about any proposed protocols and procedures they may have.


Please be advised that SNOMED International will cancel the 2020 April Business Meetings if we feel that the COVID-19 risk to our Community of Practice is too great, and we will advise with sufficient notice to respect the impact to your travel plans.


We encourage our attendees to bookmark the April Business Meeting event page to keep up to date on relevant news items.  We also encourage you to monitor your relevant government department websites for the latest advice regarding travel to the UK.


If you have any questions, please click here to contact the SNOMED International Events Team.  Assuming circumstances remain unchanged, we look forward to seeing you in London.

SNOMED International is pleased to announce a recent partnership with the University of Eastern Finland to deliver SNOMED CT education as an approved delivery agent in Finland.

The University of Eastern Finland and SNOMED International have struck an agreement to deliver mutually agreed upon SNOMED CT educational content including the organization's professionally curated Foundation course, with the potential to also offer the Implementation Course and suite of Authoring courses. 

As a result of this agreement, the University of Eastern Finland will serve as an extension of the SNOMED International Education Program within parts of Finland and be empowered to issue course completion certificates and certifications as applicable.


Read the full announcement on SNOMED International's website 


With the SNOMED International April 2020 Business Meetings in London approaching, we wish to provide an update about actions that the organization is taking around the novel coronavirus (COVID-19).

SNOMED International continues to closely monitor the coronavirus situation. The health risk of coronavirus for the general British public is considered low at this time, according to the latest summary from the UK government's Department of Health and Social Care. 

The April 2020 Business Meetings are proceeding as scheduled, and though we have no reason to believe that this will change, please be assured that the health, safety and well-being of our community remains our highest priority.

  • SNOMED International will continue to follow the guidance of the UK government and the World Health Organization (WHO) and will provide updates to our community where necessary;

  • We are communicating regularly with our venue, the Waldorf Hilton London, about any proposed protocols and procedures they may have;

  • We encourage our attendees to monitor their relevant government department websites for the latest advice regarding travel to the UK.

If you have any questions, please click here to contact the SNOMED Events Team.

We hope to see you in London.

We wish to remind those attending the forthcoming Business Meetings in London that the deadline for obtaining our delegate accommodation rate at the Waldorf Hilton is this Wednesday, February 19th, 2020.

If you have not already booked then we encourage you to make the most of these discounted rates at the conference venue:

  • Hilton Queen Guest Room:
    • Single occupancy £240 GBP/night
    • Double occupancy £250 GBP/night
    • Rates include full English breakfast, standard wifi access, and applicable taxes.
    • Check-in time is 15:00; check-out time is 12:00
    • Please note once the reservation has been made it becomes non changeable and non-refundable.

These rates are valid for nights between April 4th-9th, 2020. Please email the hotel directly if you need to extend your stay beyond these dates. 

Book now

Further information about the event can be found on our website:
https://www.snomed.org/news-and-events/events/business-meeting

Please contact the SNOMED Events Team (events@snomed.org) if you have any questions.

We look forward to seeing you in London!

Based on recent announcements by the World Health Organization (WHO) (Novel Coronavirus disease naming ) and the International Committee on Taxonomy of Viruses (ICTV) (Coronavirus study group), concepts recently added to SNOMED CT related to the recent outbreak of coronavirus respiratory disease have been revised.  The WHO has named the syndrome caused by this coronavirus, COVID-19.  The ICTV has named the virus “Severe acute respiratory syndrome coronavirus 2” or SARS-CoV-2. 

The Fully specified names and preferred terms (US-English and GB-English only) have been updated to reflect these new names.  As the original names associated with these concepts were known to be temporary and there is no change in the meaning of the concepts, these description changes are considered to be technical corrections and do not require the inactivation and replacement of concepts from the January 2020 release of SNOMED CT. 

Note that the following changes do not affect clinical meaning, nor the SNOMED CT concept ID available to users. All changes will be included in the July 31, 2020 SNOMED CT International Edition release.

SCTID

Description type

Original description

New description

840533007

Fully specified name

2019 novel coronavirus (organism)

Severe acute respiratory syndrome coronavirus 2 (organism)

840533007

Preferred term

2019-nCoV

SARS-CoV-2

840536004

Fully specified name

Antigen of 2019 novel coronavirus (substance)

Antigen of severe acute respiratory syndrome coronavirus 2 (substance)

840536004

Preferred term

Antigen of 2019-nCoV

Antigen of SARS-CoV-2

840534001

Fully specified name

2019 novel coronavirus vaccination (procedure)

Severe acute respiratory syndrome coronavirus 2 vaccination (procedure)

840534001

Preferred term

2019-nCoV vaccination

SARS-CoV-2 vaccination

840535000

Fully specified name

Antibody to 2019 novel coronavirus (substance)

Antibody to severe acute respiratory syndrome coronavirus 2 (substance)

840535000

Preferred term

Antibody to 2019-nCoV

Antibody to SARS-CoV-2

840546002

Fully specified name

Exposure to 2019 novel coronavirus (event)

Exposure to severe acute respiratory syndrome coronavirus 2 (event)

840546002

Preferred term

Exposure to 2019 novel coronavirus

Exposure to SARS-CoV-2

840539006

Fully specified name

Disease caused by 2019 novel coronavirus (disorder)

Disease caused by severe acute respiratory syndrome coronavirus 2 (disorder)

840539006

Preferred term

Disease caused by 2019-nCoV

COVID-19

840544004

Fully specified name

Suspected disease caused by 2019 novel coronavirus (situation)

Suspected disease caused by severe acute respiratory coronavirus 2 (situation)

840544004

Preferred term

Suspected disease caused by 2019-nCoV

Suspected disease caused by SARS-CoV-2


All previous descriptions related to these concepts have been retained to facilitate searching and mapping to descriptions that may have been used prior to these term changes.

For more information, please contact info@snomed.org 

The world is focused on the outbreak of respiratory illness caused by a novel coronavirus.  The World Health Organization (WHO) has named the syndrome caused by this coronavirus “COVID-19”, and the International Committee on Taxonomy of Viruses (ICTV) has named the virus “Severe acute respiratory syndrome coronavirus 2” or SARS-CoV-2.



Read the Article


As part of the global effort to manage and contain this global public health emergency, two global health standards organizations, Regenstrief Institute and SNOMED International, are doing their part to support care teams globally to code and track SARS-CoV-2 testing and COVID-19 cases, and by extension support clinicians and researchers in their efforts to address its containment. 

Both subject matter experts in coding and structuring clinical information, Regenstrief Institute and SNOMED International have recently introduced new content to their respective products, a laboratory and health observations oriented coding system in the case of LOINC, and a broad spectrum clinical terminology in the case of SNOMED CT. With the high rate of global adoption for both standards, LOINC and SNOMED CT have taken swift action to make this content immediately available to support those on the ground in tackling the virus.

“With novel viruses that appear to be easily transmittable, such as the coronavirus, it is vitally important that all identified cases be reported quickly for public health tracking,” said Regenstrief Research Scientist Theresa Cullen, M.D., M.S., global health expert with the Regenstrief Institute. Don Sweete from SNOMED International says “the creation of new COVID-19 and SARS-CoV-2 codes and concepts from LOINC and SNOMED CT introduce the structure in coding needed for health systems internationally to manage the outbreak. Both Cullen and Sweete agree that in possessing superior data, health leaders worldwide can engage in a higher degree of analysis to inform their outbreak management approach. Based on the formal naming of the syndrome and virus by WHO and ICTV, both organizations are presently updating their respective code and concepts to reflect the change.
 
For more information on the specific actions that each organization has taken, visit Regenstrief Institute and SNOMED International respectively.
 
Regenstrief Institute and SNOMED International mutually recognize the importance of interoperability through standardization in the pursuit of timely, safe and efficient health care and continue to work collaboratively to achieve this end. 

If you are attending at the forthcoming Business Meetings in London please note that SNOMED International has obtained delegate rates at the venue, the Waldorf Hilton:

  • Hilton Queen Guest Room:
    • Single occupancy £240 GBP/night
    • Double occupancy £250 GBP/night
    • Rates include full English breakfast, standard wifi access, and applicable taxes.
    • Check-in time is 15:00; check-out time is 12:00
    • Please note once the reservation has been made it becomes non changeable and non-refundable.

These rates are valid for nights between April 4th-9th, 2020 and are guaranteed until February 19th, 2020.

Please email the hotel directly if you need to extend your stay beyond these dates. 

Book now

Further information about the event can be found on our website:
https://www.snomed.org/news-and-events/events/business-meeting

Please contact the SNOMED Events Team (events@snomed.org) if you have any questions.

We look forward to seeing you in London!

Submit your SNOMED CT story and be part of the conversation in Lisbon, October 8-9, 2020.

Abstract submissions for oral presentations and e-posters are invited by Wednesday April 15, 2020.

All Expo presentations and posters must be related to SNOMED CT and should be informative rather than promoting a particular product or service.

They should enable attendees to enhance the breadth of their knowledge of SNOMED CT and be aligned with one of three program streams:

Demonstrating Implementation Excellence
Presentations exploring practical, first-hand experience in using SNOMED CT. Implementers from healthcare organizations, government agencies and industry will share their lessons learned and benefit realization achievements.

Enhancing Clinical Practice
Presentations focused on the application of SNOMED CT in clinical settings and clinical research; aimed at enhancing the patient experience, clinical outcomes, reducing costs or improving efficiency of the clinical practices. This may include such areas as precision medicine, data analytics, decision support etc.

Terminology Leading Practices
Presentations covering experience and ideas on innovative enhancements of SNOMED CT, as well as those in conjunction with other international standards, e.g., content development, mappings, description logic.

Oral presentations will be 30 minutes in length (including time for audience questions) and e-posters must be prepared using a supplied template. All presenters are required to participate in person; virtual presentations are not permitted.

Presenters will be notified of the outcome of their submissions by May 27, 2020.

Visit the conference website for more information about the event.


x



SNOMED International is pleased to advise that NHS Digital are holding a workshop on the Role of SNOMED CT, FHIR and other standards in addressing Clinical & Business needs in Lab Medicine (Pathology) at the same venue as our April conference, on the Thursday directly following the Business Meetings.

Venue Details: Waldorf Hilton Hotel, London
Date: 9th April 2020

Please click here for more information.

NHS Digital welcome participation from interested participants in other member SNOMED member countries and anyone else with an interest in this area! They have limited spaces available so please register your place by emailing pathologyanddiagnostics@nhs.net or info@snomed.org.


London, United Kingdom, Jan. 16, 2020 (GLOBE NEWSWIRE) -- SNOMED International recently presented its Award for Excellence and Lifetime Achievement Award at its Awards Gala held in conjunction with the SNOMED CT Expo 2019 hosted in Kuala Lumpur, Malaysia last October.  Award recipients are nominated from among the community to recognize exceptional contributors to the evolution and ongoing guardianship of SNOMED CT. 

The 2019 Award for Excellence was presented to Dr. Mark Jurkovich, and the Lifetime Achievement Award to 2 recipients, Dr. Stewart Jessamine and Lies van Gennip, PhD.   

Read about each of our recipients contributions on the SNOMED International website and join us in congratulating them for their ongoing dedication to SNOMED CT.